乐普医疗,300003,收入构成,报告日期,2020-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1671,933,738,44.19%,0.27% 药品制剂业务,154649,24114,130534,84.41%,47.89% 非心血管器械,130755,41819,88937,68.02%,32.63% 核心心血管介入产品,67786,15404,52382,77.28%,19.22% 乐普医疗,300003,收入构成,报告日期,2019-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 新型医疗业态,5948,-- ,-- ,--,0% 器械产品代理配送业务,48516,-- ,-- ,--,0% 医疗服务,26479,-- ,-- ,--,0% 药品-原料药,66079,-- ,-- ,--,0% 起搏器,4699,-- ,-- ,--,0% 体外诊断产品,39624,-- ,-- ,--,0% 封堵器,12977,-- ,-- ,--,0% 支架系统,179105,39288,139817,78.06%,33.79% 其他自产器械产品,42997,-- ,-- ,--,0% 外科器械,34347,-- ,-- ,--,0% 其他(补充),-- ,1978,-- ,--,0% 药品-制剂,318783,44786,273997,85.95%,66.21% 乐普医疗,300003,收入构成,报告日期,2019-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 药品-硫酸氢氯吡格雷,57117,5962,51155,89.56%,25.1% 其他(补充),1378,581,798,57.87%,0.39% 药品-原料药,40520,21557,18964,46.8%,9.31% 药品-阿托伐他汀钙片,64732,5308,59424,91.8%,29.16% 支架系统,90878,17444,73434,80.8%,36.04% 乐普医疗,300003,收入构成,报告日期,2018-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 药品-阿托伐他汀钙片,88503,7314,81189,91.74%,27.27% 其他药品,58376,-- ,-- ,--,0% 器械产品代理配送业务,41478,-- ,-- ,--,0% 外科器械,24783,-- ,-- ,--,0% 药品-硫酸氢氯吡格雷,117987,13557,104430,88.51%,35.08% 体外诊断产品,32000,-- ,-- ,--,0% 支架系统,141347,29287,112060,79.28%,37.64% 医疗服务,22405,-- ,-- ,--,0% 药品-原料药,52321,-- ,-- ,--,0% 新型医疗业态,5303,-- ,-- ,--,0% 其他自产器械产品,51128,-- ,-- ,--,0% 乐普医疗,300003,收入构成,报告日期,2018-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 药品-硫酸氢氯吡格雷,56601,6184,50417,89.07%,35.49% 药品-阿托伐他汀钙片,36206,3840,32366,89.39%,22.78% 支架系统,71201,12939,58262,81.83%,41.01% 其他(补充),1689,675,1014,60.03%,0.71% 乐普医疗,300003,收入构成,报告日期,2017-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),126263,2186,124078,98.27%,44.81% 外科器械产品,22092,-- ,-- ,--,0% 体外诊断试剂及设备,27820,-- ,-- ,--,0% 起搏器,18958,-- ,-- ,--,0% 药品-阿托伐他汀钙片,36375,-- ,-- ,--,0% 药品-硫酸氢氯吡格雷,68006,8442,59564,87.59%,21.51% 药品-原料药,37105,-- ,-- ,--,0% 支架系统,117144,23898,93246,79.6%,33.68% 乐普医疗,300003,收入构成,报告日期,2017-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1498,453,1045,69.75%,1.34% 药品-硫酸氢氯吡格雷,33197,4557,28640,86.27%,36.79% 支架系统,58961,10790,48170,81.7%,61.87% 乐普医疗,300003,收入构成,报告日期,2016-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,86916,56399,30517,35.11%,14.44% 外科器械产品,13880,3172,10709,77.15%,5.07% 封堵器,10182,774,9408,92.4%,4.45% 体外诊断试剂及设备,20670,6886,13785,66.69%,6.52% 起搏器,16901,10014,6886,40.75%,3.26% 药品-阿托伐他汀钙片,16713,2052,14661,87.72%,6.94% 药品-硫酸氢氯吡格雷,44178,6962,37216,84.24%,17.61% 药品-原料药,40842,27461,13381,32.76%,6.33% 支架系统,96492,21694,74798,77.52%,35.39% 乐普医疗,300003,收入构成,报告日期,2016-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1015,316,699,68.84%,1.05% 药品-硫酸氢氯吡格雷,21048,3305,17743,84.3%,26.58% 药品-原料药,22310,15894,6416,28.76%,9.61% 支架系统,50328,8433,41895,83.24%,62.76% 乐普医疗,300003,收入构成,报告日期,2015-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,71265,43761,27504,38.59%,17.96% 外科器械产品,6095,1243,4852,79.6%,3.17% 封堵器,10071,758,9313,92.47%,6.08% 体外诊断试剂及设备,13612,4213,9400,69.05%,6.14% 起搏器,16913,9088,7825,46.27%,5.11% 药品-阿托伐他汀钙片,6254,831,5423,86.71%,3.54% 药品-硫酸氢氯吡格雷,19801,4156,15645,79.01%,10.21% 药品-原料药,50912,41628,9284,18.24%,6.06% 支架系统,81947,18016,63931,78.02%,41.74% 乐普医疗,300003,收入构成,报告日期,2015-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他代理业务,13249,11641,1608,12.13%,2.96% 支架系统,43391,7731,35660,82.18%,65.62% 药品,43678,26983,16694,38.22%,30.72% 其他(补充),789,409,380,48.19%,0.7% 乐普医疗,300003,收入构成,报告日期,2014-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 体外诊断试剂,6094,1461,4633,76.02%,4.37% 支架系统,68642,10636,58007,84.51%,54.7% 其他(补充),814,137,677,83.14%,0.64% 医疗服务,17141,6541,10600,61.84%,10% 移动医疗,604,412,192,31.82%,0.18% 其他代理业务,31027,25642,5385,17.36%,5.08% 封堵器,8691,955,7735,89.01%,7.3% 其他,318,73,245,76.96%,0.23% 药品,17887,6099,11788,65.9%,11.12% 起搏器,15645,8871,6774,43.3%,6.39% 乐普医疗,300003,收入构成,报告日期,2014-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),379,-- ,-- ,--,0% 其他,9750,3523,6227,63.87%,12.49% 药品,7205,2640,4566,63.37%,9.15% 其他代理业务,14032,12449,1582,11.28%,3.17% 起搏器及代理,8181,4737,3444,42.1%,6.91% 封堵器,4460,492,3968,88.97%,7.96% 支架系统,35227,5142,30084,85.4%,60.32% 乐普医疗,300003,收入构成,报告日期,2013-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),533,102,431,80.85%,0.48% 其他,21509,10857,10652,49.52%,11.84% 药品,5743,2397,3346,58.26%,3.72% 其他代理业务,15661,12130,3531,22.55%,3.93% 起搏器及代理,13182,6613,6569,49.83%,7.3% 封堵器,7615,728,6888,90.44%,7.66% 支架系统,66083,7550,58533,88.58%,65.07% 乐普医疗,300003,收入构成,报告日期,2013-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 代理及经销产品,15897,10195,5702,35.87%,7.13% 其中:其他,6759,3272,3487,51.59%,4.36% 其中:封堵器,4449,552,3897,87.59%,4.87% 其中:支架系统,33447,3698,29749,88.94%,37.2% 主营产品,44655,7522,37133,83.15%,46.43% 乐普医疗,300003,收入构成,报告日期,2012-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 代理及经销产品,13961,10377,3584,25.67%,2.28% 其中:其他,9860,3697,6163,62.5%,3.92% 其中:封堵器,7843,742,7100,90.53%,4.52% 其中:支架系统,69929,6387,63542,90.87%,40.42% 主营产品,87631,10826,76805,87.65%,48.86% 乐普医疗,300003,收入构成,报告日期,2012-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 代理及经销产品,6032,4181,1851,30.69%,2.25% 其中:其他,4731,1746,2985,63.09%,3.62% 其中:支架系统,36013,2179,33835,93.95%,41.05% 主营产品,44637,4355,40282,90.24%,48.88% 其中:封堵器,3893,430,3463,88.95%,4.2% 乐普医疗,300003,收入构成,报告日期,2011-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 代理及经销产品,9221,6538,2683,29.09%,3.53% 其它,9799,4564,5234,53.42%,6.89% 封堵器,6624,573,6051,91.36%,7.97% 支架系统,66342,4390,61952,93.38%,81.6% 乐普医疗,300003,收入构成,报告日期,2011-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 代理及经销产品,5140,3503,1637,31.84%,4.17% 其他,3256,1249,2007,61.63%,5.11% 封堵器,3350,383,2967,88.57%,7.55% 支架系统,35166,2500,32666,92.89%,83.17% 乐普医疗,300003,收入构成,报告日期,2010-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 代理及经销产品,8027,5368,2659,33.12%,4.16% 其它,5616,3403,2212,39.4%,3.46% 封堵器,5419,490,4929,90.96%,7.72% 支架系统,57949,3892,54057,93.28%,84.65% 乐普医疗,300003,收入构成,报告日期,2010-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 代理及经销产品,4548,3089,1459,32.08%,4.51% 3、其它,1123,590,532,47.41%,1.65% 2、封堵器,2618,262,2356,89.98%,7.29% 1、支架系统,29983,2002,27981,93.32%,86.55% 乐普医疗,300003,收入构成,报告日期,2009-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 代理及经销产品,6360,4642,1719,27.02%,3.63% 其它,1760,1,1759,99.94%,3.71% 封堵器,4235,590,3645,86.07%,7.69% 支架系统,44165,3905,40260,91.16%,84.97% 乐普医疗,300003,收入构成,报告日期,2009-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 3、其它,604,-- ,-- ,--,--% 2、封堵器,2273,-- ,-- ,--,--% 1、支架系统,22088,-- ,-- ,--,--% 乐普医疗,300003,收入构成,报告日期,2008-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其它,1069,-- ,-- ,--,--% 封堵器,536,-- ,-- ,--,--% 支架系统,34090,-- ,-- ,--,--% 代理及经销产品,3692,-- ,-- ,--,--% 乐普医疗,300003,收入构成,报告日期,2007-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 代理及经销产品,217,-- ,-- ,--,--% 3、其它,1102,-- ,-- ,--,--% 1、支架系统,28579,-- ,-- ,--,--% 乐普医疗,300003,收入构成,报告日期,2006-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 3、其它,1086,-- ,-- ,--,--% 1、支架系统,16448,-- ,-- ,--,--%